Unlike image recognition or NLP, clinical trial data possesses a unique and complex mathematical geometry. According to Dr. Juraji, this means generic AI models are insufficient. Solving trial failures requires specialized AI built to navigate this specific, difficult data landscape.

Resolve AI trains its production debugging models not on private customer code, but on the sequence of actions humans take to solve problems. This involves long, multi-step tasks across systems like Datadog and AWS—a type of data that general-purpose models lack.

Advanced AI models are ineffective in clinical settings without a robust data layer. Ambience had to solve fundamental problems like pulling messy context from inconsistent EHRs and preserving 'decision traces,' which are often destroyed by existing systems with mutable data structures.

AI often fails at revenue cycle management because it interprets actions literally. A physical therapist might prescribe a squat not for leg strength (one billing code) but for core re-education (a different code). This clinical intent is rarely spoken aloud, so AI must understand context to bill accurately.

Despite the hype, Datycs' CEO finds that even fine-tuned healthcare LLMs struggle with the real-world complexity and messiness of clinical notes. This reality check highlights the ongoing need for specialized NLP and domain-specific tools to achieve accuracy in healthcare.

Startups like NextVisit AI, a note-taker for psychiatry, win by focusing on a narrow vertical and achieving near-perfect accuracy. Unlike general-purpose AI where errors are tolerated, high-stakes fields demand flawless execution. This laser focus on one small, profound idea allows them to build an indispensable product before expanding.

The current trend of building huge, generalist AI systems is fundamentally mismatched for specialized applications like mental health. A more tailored, participatory design process is needed instead of assuming the default chatbot interface is the correct answer.

In a fast-moving AI landscape, startups can create defensible moats by leveraging new tools to rapidly build solutions for highly specific customer needs. This deep personalization—for a niche provider, rare disease patient, or specific administrative workflow—creates a "wow moment" that large, generalist models struggle to replicate.

An AI model cleared by the FDA often underperforms in clinical practice because of site-specific variables. Different training backgrounds lead to different scanning protocols, and different equipment creates unique image characteristics. AI must be adaptable to these local 'dialects' rather than being a one-size-fits-all, frozen model.